Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1988 Dec;148(3):193-7.
doi: 10.1007/BF00441399.

Cardiomyopathy associated with carnitine loss in kidneys and small intestine

Affiliations
Case Reports

Cardiomyopathy associated with carnitine loss in kidneys and small intestine

R Rodrigues Pereira et al. Eur J Pediatr. 1988 Dec.

Abstract

A boy was first seen at the age of 1 year on account of congestive cardiomyopathy. Growth and development had been normal. Total plasma carnitine was extremely low (1.8 mumol/l; normal range: 25-64 mumol/l). No hypoglycaemia, lactic acidaemia or dicarboxylic aciduria were found. Other laboratory findings were unremarkable except for a slight deficiency in iron, vitamin D and vitamin E. Total muscle carnitine was 1.5% of normal; however, no signs or symptoms of myopathy could be detected. After carnitine loading, liver carnitine increased to 24% of normal. Isolated muscle mitochondria showed decreased oxidative capacity with all substrates tested. Stimulation of O2 uptake by adenosine diphosphate (ADP) was decreased. After loading with both intravenous and oral carnitine, there was a rise in plasma carnitine and a rapid loss in the urine and the faeces. These findings suggest a defect in the brush border carnitine transport system of the kidneys and of the small intestine. Renal clearance of carnitine was abnormally high. Therapy with 1 g oral L-carnitine/kg per day was instituted without any problems and the cardiac disease resolved within 3 months. The parents and the patient's five sibs also had low plasma carnitine but displayed no cardiomyopathy.

PubMed Disclaimer

References

    1. J Inherit Metab Dis. 1984;7 Suppl 1:38-43 - PubMed
    1. J Pediatr. 1982 Nov;101(5):700-5 - PubMed
    1. Klin Wochenschr. 1982 Apr 15;60(8):393-400 - PubMed
    1. N Engl J Med. 1980 Dec 11;303(24):1389-94 - PubMed
    1. J Pediatr. 1981 Oct;99(4):551-5 - PubMed

Publication types

LinkOut - more resources